Functional properties of the uptake of amines in immortalised peptidergic neurones (transport‐P)
暂无分享,去创建一个
[1] P. J. Salt. Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. , 1972, European journal of pharmacology.
[2] J. Windle,et al. Immortalization of hypothalamic GnRH by genetically targeted tumorigenesis , 1990, Neuron.
[3] E. Seeberg,et al. Cloning and expression of a rat brain L-glutamate transporter , 1992, Nature.
[4] W. Wetsel,et al. Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone. , 1991, Endocrinology.
[5] W. Wetsel,et al. Gonadotropin-releasing hormone neuronal cell lines. , 1992, Frontiers in neuroendocrinology.
[6] G. Radda,et al. The effect of uncouplers on catecholamine incorporation by vesicles of chromaffin granules. , 1975, The Biochemical journal.
[7] L. Iversen,et al. Inhibition of catecholamine Uptake2 by steroids in the isolated rat heart , 1970 .
[8] L. Cantley,et al. Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side , 1978, Nature.
[9] David Attwell,et al. The glial cell glutamate uptake carrier countertransports pH-changing anions , 1992, Nature.
[10] F. Maxfield. Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts , 1982, The Journal of cell biology.
[11] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[12] W. Wetsel,et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Iversen,et al. Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. , 1970, British journal of pharmacology.
[14] T. Storck,et al. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] K. Catt,et al. High‐affinity uptake of noradrenaline in postsynaptic neurones , 1993, British journal of pharmacology.
[16] L. Hösli,et al. Action and uptake of neurotransmitters in CNS tissue culture. , 1978, Reviews of physiology, biochemistry and pharmacology.
[17] H. Bönisch,et al. The Transport of Amines Across the Axonal Membranes of Noradrenergic and Dopaminergic Neurones , 1988 .
[18] H. Kimelberg,et al. High‐Affinity Uptake of [3H]Norepinephrine by Primary Astrocyte Cultures and Its Inhibition by Tricyclic Antidepressants , 1983, Journal of neurochemistry.
[19] M. Tanzer,et al. Monensin — a perturbant of cellular physiology , 1984 .
[20] J. Roberts,et al. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. , 1990, Neuron.
[21] K. Catt,et al. Calcium signaling and episodic secretion of gonadotropin-releasing hormone in hypothalamic neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] B. Hoffman,et al. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Iversen. The Uptake and Storage of Noradrenaline in Sympathetic Nerves , 1967 .
[24] Y. Gluzman. SV40-transformed simian cells support the replication of early SV40 mutants , 1981, Cell.
[25] J. P. Schwartz,et al. Accumulation of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Cultured Cerebellar Astrocytes , 1992, Journal of neurochemistry.
[26] P. Tulkens,et al. Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.
[27] B Poole,et al. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Eisenberg,et al. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter , 1992, Cell.
[29] E. Kravitz,et al. Sodium dependence of transmitter uptake at adrenergic nerve terminals. , 1966, Molecular pharmacology.
[30] J. Axelrod. Noradrenaline: fate and control of its biosynthesis. , 1971, Science.
[31] N. Nelson. Structure and pharmacology of the proton-ATPases. , 1991, Trends in pharmacological sciences.
[32] Randy D. Blakely,et al. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter , 1991, Nature.
[33] P. Pedersen,et al. Ion motive ATPases. I. Ubiquity, properties, and significance to cell function , 1987 .
[34] A. Hamberger,et al. Glial cell function: uptake of transmitter substances. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Fahim,et al. Pharmacology and toxicology of the monovalent carboxylic ionophores. , 1982, Annual review of pharmacology and toxicology.
[36] L. Iversen. THE UPTAKE OF CATECHOL AMINES AT HIGH PERFUSION CONCENTRATIONS IN THE RAT ISOLATED HEART: A NOVEL CATECHOL AMINE UPTAKE PROCESS , 1997, British journal of pharmacology.
[37] S F Campbell,et al. 2,4-Diamino-6,7-dimethoxyquinazolines. 2. 2-(4-Carbamoylpiperidino) derivatives as alpha 1-adrenoceptor antagonists and antihypertensive agents. , 1987, Journal of medicinal chemistry.
[38] S. Al-Damluji,et al. Adrenergic control of the secretion of anterior pituitary hormones. , 1993, Bailliere's clinical endocrinology and metabolism.
[39] B. Spengler,et al. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. , 1973, Cancer research.
[40] K. Altendorf,et al. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.